Cellex

Cellex, established in 2001, is a premier Contract Development and Manufacturing Organization (CDMO) with a specialized focus on cell and gene therapy. Leveraging over a decade of dedicated experience, the company serves as a critical partner for pharmaceutical firms, emerging biotech companies, and academic research institutions. Cellex is instrumental in supporting GMP-compliant CAR-T production, facilitating complex clinical trials, and providing expert consulting services tailored to advanced therapy medicinal products (ATMPs). Their comprehensive service portfolio encompasses process development, efficient cell collection, and robust supply chain management, ensuring seamless progression from preclinical research to commercial viability.

The organization operates with a team of dedicated professionals, contributing to its reputation for scientific excellence and high-quality solutions. Meet Cellex's team to understand the expertise driving their innovation. Cellex manages operations across 4 locations and employs between 500 - 1,000 individuals, underscoring its significant capacity and reach within the biotechnology sector. This scale allows them to effectively manage intricate manufacturing processes and support a diverse client base.

Cellex is committed to advancing therapeutic development by bridging the gap between scientific discovery and market accessibility. Their strategic partnerships and unwavering dedication to quality are central to their mission of helping clients bring groundbreaking drug products to patients. With a reported revenue of $27.5M, Cellex demonstrates a strong financial footing and a sustained ability to invest in cutting-edge technologies and infrastructure necessary for the rapidly evolving field of cell and gene therapy.